Differential response to heart failure medications in children
- 1 June 2018
- journal article
- review article
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 49, 27-30
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summaryThe Journal of Heart and Lung Transplantation, 2014
- Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society GuidelinesCanadian Journal of Cardiology, 2013
- Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic DysfunctionCirculation: Heart Failure, 2011
- The Impact of Changing Medical Therapy on Transplantation-Free Survival in Pediatric Dilated CardiomyopathyJACC, 2010
- Carvedilol for Children and Adolescents With Heart FailureJAMA, 2007
- Clinical Features and Outcomes of Childhood Dilated CardiomyopathyCirculation, 2006
- Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in ChildrenJAMA, 2006
- Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantationJACC, 2004
- Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialThe Lancet, 2003
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996